LBRX (LB Pharmaceuticals, Inc.) Future Price to Earnings

LB Pharmaceuticals Inc (LBRX) focuses on developing innovative treatments for mental pathologies. The absence of profitable assets makes the company dependent on the inflow of external investments, with the indicator standing at 0.00. The company's price chart reflects the dynamics of a business striving to modernize antipsychotics to reduce the risk of adverse reactions and optimize drug absorption in the treatment of schizophrenia.

Market Cap to Projected Earnings: LB Pharmaceuticals, Inc. (LBRX) for 09/12/2025 - 11/13/2026

Metric breakdowns and analytics for LB Corp (LBRX)

- current price and projected stock value:

Stock Quotes LB Pharmaceuticals|LBRX - Fair Value Consensus

- business market valuation indicators:

Market Value LB Pharmaceuticals, Inc.|LBRX - Full Business Value

- balance sheet equity data:

Net Assets per Single Share LB Pharmaceuticals|LBRX - Book Valuation of Business|Market Cap to Net Assets Ratio lbpharma.us|LBRX - Company Assets

- company total debt and liquidity indicators:

- company profitability and valuation multiples indicators:

LBRX - Company Net Income|Future Profit LB Pharmaceuticals Inc|LBRX - Company Value to Net Income|Future Price to Earnings LB Pharma|LBRX - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple LB Pharmaceuticals, Inc.|LBRX - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) LB Pharmaceuticals|LBRX - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months lbpharma.us|LBRX - Earnings per share increase in current year|Net earnings per share growth forecast for next year LB Pharmaceuticals Inc

- revenue and sales proceeds data:

LBRX - Company Sales|Projected Sales Volume LB Pharmaceuticals|LBRX - P/S Multiple|Forward P/S Multiple LB Pharmaceuticals, Inc.

Fundamental valuation:LBRX LB Pharmaceuticals

A qualitative asset valuation requires an analysis of expected earnings relative to the current share price. This ratio correlates market capitalization with projected profits, accounting for the impact of tax incentives and government expenditures. The dynamics of the business's forward P/E allow for the determination of the long-term value trend while avoiding the traps of undervalued assessments. It is critical for investors to weigh this data against operational risks. For LB Pharmaceuticals Inc (LBRX), an asset-light model utilizing production outsourcing reduces capital expenditures, which directly impacts future profitability.

Competitors of LB Pharmaceuticals Inc (LBRX)